المؤلفون: Ronglai Shen, M. Catherine Pietanza, William Pao, Agnes Viale, Vincent A. Miller, Dana T. Aftab, Zhiguo Zhao, Mark G. Kris, Thomas J. Stout, Naiyer A. Rizvi, Juliann Chmielecki, Xi Chen, Katherine E. Hutchinson

المصدر: Journal of Thoracic Oncology. (2):434-442

مصطلحات موضوعية: Lung Neoplasms, medicine.medical_treatment, Afatinib, Pharmacology, T790M, 0302 clinical medicine, Non-small cell lung cancer, Antineoplastic Combined Chemotherapy Protocols, Tumor Cells, Cultured, EGFR tyrosine kinase inhibitors, In Situ Hybridization, Fluorescence, EGFR inhibitors, Oligonucleotide Array Sequence Analysis, 0303 health sciences, Gefitinib, Prognosis, 3. Good health, ErbB Receptors, Oncology, Erlotinib, 030220 oncology & carcinogenesis, XL647, Adenocarcinoma, medicine.drug, Pulmonary and Respiratory Medicine, Immunoblotting, Article, 03 medical and health sciences, Erlotinib Hydrochloride, Clinical Trials, Phase II as Topic, medicine, Biomarkers, Tumor, Humans, Lung cancer, Protein Kinase Inhibitors, 030304 developmental biology, Neoplasm Staging, Chemotherapy, business.industry, Gene Expression Profiling, medicine.disease, Small Cell Lung Carcinoma, EGFR mutations, respiratory tract diseases, Drug Resistance, Neoplasm, Mutation, Cancer research, Quinazolines, Acquired resistance, business, Azabicyclo Compounds

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deaf6ffaaa208d53706baea712d2ba30Test

المؤلفون: Antoinette J. Wozniak, Lance K. Heilbrun, John C. Ruckdeschel, Shirish M. Gadgeel, Raghu Venkatramanamoorthy, Elisabeth I. Heath

المصدر: Journal of Thoracic Oncology. (4):299-305

مصطلحات موضوعية: Male, Oncology, Lung Neoplasms, Administration, Oral, Phases of clinical research, non-small cell lung cancer (NSCLC), 0302 clinical medicine, Non-small cell lung cancer, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, heterocyclic compounds, Epidermal growth factor receptor, Cyclooxygenase-2, skin and connective tissue diseases, EGFR inhibitors, Sulfonamides, 0303 health sciences, biology, Gefitinib, Middle Aged, 3. Good health, ErbB Receptors, 030220 oncology & carcinogenesis, COX-2 inhibitor, Female, medicine.drug, Adult, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Maximum Tolerated Dose, Risk Assessment, Drug Administration Schedule, 03 medical and health sciences, Internal medicine, Confidence Intervals, medicine, Humans, neoplasms, Aged, Neoplasm Staging, Platinum, Probability, 030304 developmental biology, Cyclooxygenase 2 Inhibitors, Dose-Response Relationship, Drug, Performance status, business.industry, medicine.disease, Survival Analysis, respiratory tract diseases, Drug Resistance, Neoplasm, Celecoxib, Quinazolines, biology.protein, Pyrazoles, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bb692104c65416f5f889fa950481ae1Test

المؤلفون: Takayuki Nakagawa, Junya Nakade, Shinji Takeuchi, Seiji Yano, Kunio Matsumoto, Shigeki Nanjo, Kazuo Yasumoto, Lu Zhao, Daisuke Ishikawa, Hiromichi Ebi, Kazuhiko Yonekura, Tadaaki Yamada, Takako Sano

المصدر: ResearcherID
Journal of Thoracic Oncology

مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, Lung Neoplasms, Angiogenesis, Pyridines, Epidermal growth factor receptor-tyrosine kinase inhibitor resistance, Epidermal growth factor receptor mutation, chemistry.chemical_compound, Mice, Antineoplastic Combined Chemotherapy Protocols, Epidermal growth factor receptor, Phosphorylation, Erlotinib Hydrochloride, EGFR inhibitors, Hepatocyte growth factor, biology, Neovascularization, Pathologic, Thiourea, Proto-Oncogene Proteins c-met, Vascular endothelial growth factor, Bevacizumab, ErbB Receptors, Oncology, Quinolines, Erlotinib, Translational Oncology, Lung cancer, Tyrosine kinase, medicine.drug, Pulmonary and Respiratory Medicine, Mice, Nude, Adenocarcinoma, Antibodies, Monoclonal, Humanized, Crizotinib, Cell Line, Tumor, medicine, Animals, Humans, Cell Proliferation, business.industry, Original Articles, respiratory tract diseases, chemistry, Drug Resistance, Neoplasm, Cancer research, biology.protein, Quinazolines, Pyrazoles, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de12b96216b02d6bcb6be0ed9cde8656Test

المؤلفون: William B. Fisher, Michael L. Titzer, Anuj K. Agarwala, Menggang Yu, Beth E. Juliar, T. Breen, John McClean, Lawrence H. Einhorn, D. Bruetman, Nasser H. Hanna, David Taber

المصدر: Journal of Thoracic Oncology. (4):374-379

مصطلحات موضوعية: Adult, Male, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Phases of clinical research, Adenocarcinoma, Disease-Free Survival, Gefitinib, Non-small cell lung cancer, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, Lung cancer, Survival rate, Aged, Neoplasm Staging, EGFR inhibitors, Aged, 80 and over, Sulfonamides, business.industry, Combination chemotherapy, Middle Aged, medicine.disease, Survival Rate, Regimen, Celecoxib, Carcinoma, Squamous Cell, Quinazolines, Pyrazoles, Female, business, Follow-Up Studies, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9abeb2524197290a21b83aff4b95d2Test

المؤلفون: Caroline Dive, Ruth A. Roberts, Luke R. Harrison, Flavia Moreira-Leite, Alexandr Mironov

المصدر: Journal of Thoracic Oncology. (6):765-777

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Cell signaling, Lung Neoplasms, Pyridines, Antineoplastic Agents, Protein Serine-Threonine Kinases, EGFR T790M, T790M, Gefitinib, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, medicine, Autophagy, Humans, Epidermal growth factor receptor, Phosphorylation, Extracellular Signal-Regulated MAP Kinases, Furans, Cell Proliferation, Phosphoinositide-3 Kinase Inhibitors, EGFR inhibitors, biology, business.industry, Cell growth, TOR Serine-Threonine Kinases, PI-3K/mTOR inhibition, Intracellular Signaling Peptides and Proteins, SCLC, Cell biology, respiratory tract diseases, ErbB Receptors, Pyrimidines, Oncology, Drug Resistance, Neoplasm, Mutation, Quinazolines, biology.protein, Cyclin-dependent kinase 8, Erlotinib, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993ed3f981d165f82ee9e649371ee421Test